跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ADENOSINA HIKMA 6 MG/2ML SOLUCION INYECTABLE EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ADENOSINA HIKMA 6 MG/2ML SOLUCION INYECTABLE EFG
Approved
STANDARD
ADENOSINA HIKMA 6 MG/2ML SOLUCION INYECTABLE EFG
Hikma Farmaceutica (Portugal) S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 11, 2021
Approval ID
3999325e4760ec97
Company
Hikma Farmaceutica (Portugal) S.A.
Type
Standard
Approval Details
Approval Id
3999325e4760ec97
Drug Cima Aemps Name
ADENOSINA HIKMA 6 MG/2ML SOLUCION INYECTABLE EFG
Register Number
86371
Holder Company Name
Hikma Farmaceutica (Portugal) S.A.
Marketing Company Name
Hikma España, S.L.U.
Holder Company Detail Path
/organization/hikma-farmaceutica-portugal-s-a
Authorization Date
2021-11-11
Dosage Form
SOLUCIÓN INYECTABLE
Dose
3 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Hikma Farmaceutica (Portugal) S.A.
Company Detail Path
/organization/hikma-farmaceutica-portugal-s-a
Company Information
Pharmaceutical Company Name
HIKMA FARMACÊUTICA (PORTUGAL), S.A.
Country Name
Portugal
City Name
terrugem snt,lisboa,country_pt
Address
ESTRADA RIO DA MÓ, 8/8A/B
Active Ingredients
ADENOSINA
3 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 11, 2021
Approval ID
3999325e4760ec97
Type
Standard
Back to CIMA-AEMPS Approvals